ArticleScientific reports2026
A modular platform for automated organoid culture and longitudinal imaging.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microfluidic Control of Dorsal-Ventral Patterning Within a Single Forebrain Organoid.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Organoids, 3D tissue cultures that mimic real organs, offer valuable models for research. Traditional culture methods rely on manual feeding and orbital shakers, making them labor-intensive and inconsistent. Microfluidic systems have shown their potential to improve reproducibility by controlling media exchange and culture conditions, yet most still require standard incubators, which limit continuous monitoring due to space and humidity constraints. To address this, we developed a modular platform that integrates automated feeding, real-time imaging, and environmental control, eliminating the need for a conventional incubator. A key feature is a vertically oriented PDMS/glass chip that supports precise media delivery and monitoring while preserving incubation conditions, making it ideal for morphological studies. We demonstrated the platform's ability to maintain metabolic stability and media distribution over time using cerebral organoids. This platform improves organoid research by combining microfluidics, automation, and imaging, enhancing disease modeling, drug testing, and regenerative medicine applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.